Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Sazani

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Progress in Molecular and Subcellular Biology|December 24, 2002
Modulation of alternative splicing by antisense oligonucleotidesP Sazani, R Kole
Current Opinion in Molecular Therapeutics|August 11, 2001
Antisense effects in the cell nucleus: modification of splicingR Kole, P Sazani
Cellular and Molecular Life Sciences : CMLS|June 27, 2003
Antisense-mediated redirection of mRNA splicingM Vacek, P Sazani, R Kole
Current Cancer Drug Targets|August 22, 2002
Modification of alternative splicing by antisense oligonucleotides as a potential chemotherapy for cancer and other diseasesD R Mercatante, P Sazani, R Kole
Pharmaceutical Research|January 22, 2000
PAMAM dendrimers as delivery agents for antisense oligonucleotidesH Yoo, P Sazani, R L Juliano
Nucleic Acids Research|September 28, 2001
Nuclear antisense effects of neutral, anionic and cationic oligonucleotide analogsP Sazani, S H Kang, M A Maier, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Progress in Molecular and Subcellular Biology|December 24, 2002
Modulation of alternative splicing by antisense oligonucleotidesP Sazani, R Kole
Current Opinion in Molecular Therapeutics|August 11, 2001
Antisense effects in the cell nucleus: modification of splicingR Kole, P Sazani
Cellular and Molecular Life Sciences : CMLS|June 27, 2003
Antisense-mediated redirection of mRNA splicingM Vacek, P Sazani, R Kole
Current Cancer Drug Targets|August 22, 2002
Modification of alternative splicing by antisense oligonucleotides as a potential chemotherapy for cancer and other diseasesD R Mercatante, P Sazani, R Kole
Pharmaceutical Research|January 22, 2000
PAMAM dendrimers as delivery agents for antisense oligonucleotidesH Yoo, P Sazani, R L Juliano
Nucleic Acids Research|September 28, 2001
Nuclear antisense effects of neutral, anionic and cationic oligonucleotide analogsP Sazani, S H Kang, M A Maier, et al.
Pageof 1